NCT00176813View on ClinicalTrials.gov

Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2006

Conditions
Pancreatic Cancer
Interventions
DRUG

Gemcitabine

DRUG

Cisplatin

DRUG

Celecoxib

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Barbara Ann Karmanos Cancer Institute

OTHER

lead

University of Michigan Rogel Cancer Center

OTHER

NCT00176813 - Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter